Rockefeller Capital Management
IMVT icon

Rockefeller Capital Management’s Immunovant IMVT Stock Holding History

Rockefeller Capital Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.4K Sell
1,956
-1,360
-41% -$41.4K ﹤0.01% 3142
2026
Q1 		$82.4K Buy
3,316
+2,647
+396% +$68.5K ﹤0.01% 2988
2025
Q4 		$17K Buy
+669
New +$14.9K ﹤0.01% 3584
2023
Q1 		– Sell
-224
Closed -$3K – 2910
2022
Q4 		$3K Hold
224
– – ﹤0.01% 3470
2022
Q3 		$1K Hold
224
– – ﹤0.01% 3728
2022
Q2 		$0 Buy
+224
New +$968 ﹤0.01% 4242

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Rockefeller Capital Management's IMVT Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Immunovant (IMVT) stake by 41% in Q2 2026, selling an estimated $41.4K and leaving 1,956 shares worth $75.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3142.

Rockefeller Capital Management first reported a position in IMVT in Q2 2022 and has held it in 6 quarters since. The position peaked at $82.4K in Q1 2026. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Rockefeller Capital Management held 1,956 shares of Immunovant worth $75.4K as of Q2 2026.
  • Rockefeller Capital Management sold 1,360 Immunovant shares in Q2 2026, an estimated $41.4K.
  • Immunovant made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3142 holding.
  • Rockefeller Capital Management first reported a position in Immunovant in Q2 2022 and has held it in 6 quarters since.
  • Rockefeller Capital Management's Immunovant position peaked at $82.4K in Q1 2026.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.